Johnson & Johnson Agrees to $5.5 Billion Settlement in Talc Cancer Lawsuits
Johnson & Johnson (J&J) has announced a $5.5 billion settlement to resolve tens of thousands of lawsuits alleging that its…
Ovarian Cancer
Read More
ICMR Supports Nationwide Trial to Study Reduced-Cost PARP Inhibitor Dosing in Ovarian Cancer
The Indian Council of Medical Research (ICMR) has funded a new pan-India clinical trial to examine a more affordable and…
Why Women in India Face More Cancer Cases, But Men Die More Often?
India’s cancer statistics reveal a striking paradox: women are more likely to be diagnosed with cancer, but men are more…
Andhra Pradesh Leads the Way with India’s First Empowering Cancer Screening Program for Women
Andhra Pradesh has recently made a groundbreaking move by launching India’s first dedicated cancer screening initiative for women. This initiative…
Endometriosis Raises Ovarian Cancer Risk: Need for Better Screening
Recent research has highlighted a concerning link between severe forms of endometriosis and an increased risk of ovarian cancer. This…